| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $169.4M | +52.5% |
| Cost of Revenue | $85.9M | +21.7% |
| Gross Profit | $83.4M | +106.2% |
| R&D Expense | $65.2M | +12.2% |
| SG&A Expense | $64.6M | +10.1% |
| Operating Income | -$74.0M | +29.0% |
| Pre-tax Income | -$63.3M | +34.4% |
| Income Tax | -$2.9M | -646.6% |
| Net Income | -$60.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.4M | +48.0% |
| Short-term Investments | $141.2M | +11.6% |
| Accounts Receivable | $27.8M | +54.7% |
| Inventory | $23.6M | +43.5% |
| Current Assets | $278.9M | +26.9% |
| Total Assets | $349.5M | +26.6% |
| Current Liabilities | $71.0M | -9.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.0M | -18.6% |
| Capital Expenditures | $24.9M | +562.8% |
| Investing Cash Flow | -$36.3M | -347.4% |
| Financing Cash Flow | $97.6M | +534.1% |
| Free Cash Flow | -$64.8M | -73.2% |
| +37.8% |
| EPS (Basic) | -$1.07 | +48.6% |
| EPS (Diluted) | -$1.07 | +48.6% |
| Total Liabilities |
| $87.8M |
| -7.8% |
| Stockholders' Equity | $261.7M | +44.7% |